News Page
Published December 1, 2025
Marex promised strength. Solid liquidity, fast growth, and reliable profits. Investors believed it. But cracks started to show.
In August 2024, Marex claimed billions in cash and said it could handle any market storm. By fall, executives praised “excess liquidity” from structured notes — money that wasn’t true earnings. Then in March 2025, revenue dropped sharply. The company blamed low volatility, but the truth was deeper.
According to the complaint, Marex used debt and internal transfers to pad its balance sheet and mask weak cash flow. What looked like stability was smoke and mirrors.
Investors were blindsided. Confidence collapsed. The stock tumbled.
Now, more investors are joining the lawsuit.